DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis

Journal of Cell Science

Volumn 129, Issue 20, 2016, Pages 3816-3831

  Knopp, Paul ^a   Krom, Yvonne D ^b   Banerji, Christopher R S ^a,c   Panamarova, Maryna ^a   Moyle, Louise A ^a   den Hamer, Bianca ^b   van der Maarel, Silvére M ^b   Zammit, Peter S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

DUX4; DUX4c; FSHD; Satellite cell; Skeletal muscle; Stem cells; Transcriptome

Indexed keywords

DUX4 PROTEIN; DUX4C PROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; DUX4 PROTEIN, HUMAN; DUX4 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTROMERE; CONTROLLED STUDY; DOWN REGULATION; DUX4 GENE; DUX4C GENE; GENE; GENE ACTIVATION; GENE LOCUS; GENE REPRESSION; GENETIC TRANSCRIPTION; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SATELLITE CELL; TRANSCRIPTOMICS; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL SHAPE; GENETICS; HUMAN; METABOLISM; REGENERATION; SKELETAL MUSCLE; SKELETAL MUSCLE CELL; SKELETAL MUSCLE SATELLITE CELL; STEM CELL; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL SHAPE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELLS; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 84995387826     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.180372     Document Type: Article

References (63)

1. Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I. et al. (2009). DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS ONE 4, e7482.
2. Banerji, C. R. S., Miranda-Saavedra, D., Severini, S., Widschwendter, M., Enver, T., Zhou, J. X. and Teschendorff, A. E. (2013). Cellular network entropy as the energy potential in Waddington's differentiation landscape. Sci. Rep. 3, 3039.
3. Banerji, C. R. S., Knopp, P., Moyle, L. A., Severini, S., Orrell, R. W., Teschendorff, A. E. and Zammit, P. S. (2015a). beta-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy. J. R. Soc. Interface 12, 20140797.
4. Banerji, C. R. S., Severini, S., Caldas, C. and Teschendorff, A. E. (2015b). Intratumour signalling entropy determines clinical outcome in breast and lung cancer. PLoS Comput. Biol. 11, e1004115.
5. Barro, M., Carnac, G., Flavier, S., Mercier, J., Vassetzky, Y. and Laoudj-Chenivesse, D. (2008). Myoblasts from affected and non affected FSHD muscles exhibit morphological differentiation defects. J. Cell Mol. Med. 14, 275-289.
6. Block, G. J., Narayanan, D., Amell, A. M., Petek, L. M., Davidson, K. C., Bird, T. D., Tawil, R., Moon, R. T. and Miller, D. G. (2013). Wnt/beta-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. Hum. Mol. Genet. 22, 4661-4672.
7. Bosnakovski, D., Lamb, S., Simsek, T., Xu, Z., Belayew, A., Perlingeiro, R. and Kyba, M. (2008a). DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp. Neurol. 214, 87-96.
8. Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppee, F. et al. (2008b). An isogenetic myoblast expression screen identifies DUX4-mediated FSHDassociated molecular pathologies. EMBO J. 27, 2766-2779.
9. Cabianca, D. S., Casa, V., Bodega, B., Xynos, A., Ginelli, E., Tanaka, Y. and Gabellini, D. (2012). A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 149, 819-831.
10. Caruso, N., Herberth, B., Bartoli, M., Puppo, F., Dumonceaux, J., Zimmermann, A., Denadai, S., Lebosse, M., Roche, S., Geng, L. et al. (2013). Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet 9, e1003550.
11. Celegato, B., Capitanio, D., Pescatori, M., Romualdi, C., Pacchioni, B., Cagnin, S., Vigano, A., Colantoni, L., Begum, S., Ricci, E. et al. (2006). Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6, 5303-5321.
12. Choi, S. H., Gearhart, M. D., Cui, Z., Bosnakovski, D., Kim, M., Schennum, N. and Kyba, M. (2016). DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. Nucleic Acids Res 44, 5161-5173.
13. Clapp, J., Mitchell, L. M., Bolland, D. J., Fantes, J., Corcoran, A. E., Scotting, P. J., Armour, J. A. L. and Hewitt, J. E. (2007). Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 264-279.
14. Dandapat, A., Bosnakovski, D., Hartweck, L. M., Arpke, R. W., Baltgalvis, K. A., Vang, D., Baik, J., Darabi, R., Perlingeiro, R. C. R., Hamra, F. K. et al. (2014). Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene. Cell Rep. 8, 1484-1496.
15. Dee, K., Freer, M., Mei, Y. and Weyman, C. M. (2002). Apoptosis coincident with the differentiation of skeletal myoblasts is delayed by caspase 3 inhibition and abrogated by MEK-independent constitutive Ras signaling. Cell Death Differ. 9, 209-218.
16. Deenen, J. C.W., Arnts, H., van der Maarel, S. M., Padberg, G.W., Verschuuren, J. J. G. M., Bakker, E., Weinreich, S. S., Verbeek, A. L. M. and van Engelen, B. G. M. (2014). Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 83, 1056-1059.
17. Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Matteotti, C., van Acker, A. M., Leo, O. et al. (2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. USA 104, 18157-18162.
18. Feng, Q., Snider, L., Jagannathan, S., Tawil, R., van der Maarel, S. M., Tapscott, S. J. and Bradley, R. K. (2015). A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy. Elife 4, doi: 10.7554/eLife.04996.
19. Ferreboeuf, M., Mariot, V., Bessieres, B., Vasiljevic, A., Attie-Bitach, T., Collardeau, S., Morere, J., Roche, S., Magdinier, F., Robin-Ducellier, J. et al. (2014). DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum. Mol. Genet. 23, 171-181.
20. Ferri, G., Huichalaf, C. H., Caccia, R. and Gabellini, D. (2015). Direct interplay between two candidate genes in FSHD muscular dystrophy. Hum. Mol. Genet. 24, 1256-1266.
21. Fitzsimons, R. B. (2011). Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt? Neuromuscul. Disord. 21, 263-271.
22. Flanigan, K. M., Coffeen, C. M., Sexton, L., Stauffer, D., Brunner, S. and Leppert, M. F. (2001). Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul. Disord. 11, 525-529.
23. Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., Angeletti, B., Ciscato, P., Pellegrino, M. A., Bottinelli, R. et al. (2006). Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439, 973-977.
24. Gabriels, J., Beckers, M.-C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S. M., Padberg, G. W., Frants, R. R., Hewitt, J. E., Collen, D. et al. (1999). Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236, 25-32.
25. Geng, L. N., Yao, Z., Snider, L., Fong, A. P., Cech, J. N., Young, J. M., van der Maarel, S. M., Ruzzo, W. L., Gentleman, R. C., Tawil, R. et al. (2012). DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev. Cell 22, 38-51.
26. Giussani, M., Cardone, M. F., Bodega, B., Ginelli, E. and Meneveri, R. (2012). Evolutionary history of linked D4Z4 and Beta satellite clusters at the FSHD locus (4q35). Genomics 100, 289-296.
27. Hendzel, M. J., Wei, Y., Mancini, M. A., Van Hooser, A., Ranalli, T., Brinkley, B. R., Bazett-Jones, D. P. and Allis, C. D. (1997). Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360.
28. Hewitt, J. E., Lyle, R., Clark, L. N., Valleley, E. M., Wright, T. J., Wijmenga, C., van Deutekom, J. C. T., Francis, F., Sharpe, P. T., Hofker, M. et al. (1994). Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 3, 1287-1295.
29. Himeda, C. L., Debarnot, C., Homma, S., Beermann, M. L., Miller, J. B., Jones, P. L. and Jones, T. I. (2014). Myogenic Enhancers Regulate Expression of the Facioscapulohumeral Muscular Dystrophy-Associated DUX4 Gene. Mol. Cell. Biol. 34, 1942-1955.
30. Huang, D. W., Sherman, B. T. and Lempicki, R. A. (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13.
31. Huang, D. W., Sherman, B. T. and Lempicki, R. A. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
32. Jones, T. I., Chen, J. C. J., Rahimov, F., Homma, S., Arashiro, P., Beermann, M. L., King, O. D., Miller, J. B., Kunkel, L. M., Emerson, C. P., Jr et al. (2012). Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum. Mol. Genet. 21, 4419-4430.
33. Kawamura-Saito, M., Yamazaki, Y., Kaneko, K., Kawaguchi, N., Kanda, H., Mukai, H., Gotoh, T., Motoi, T., Fukayama, M., Aburatani, H. et al. (2006). Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum. Mol. Genet. 15, 2125-2137.
34. Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Matteotti, C., Arias, C., Corona, E. D., Nunez, N. G., Leo, O. et al. (2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord. 17, 611-623.
35. Krom, Y. D., Thijssen, P. E., Young, J. M., den Hamer, B., Balog, J., Yao, Z., Maves, L., Snider, L., Knopp, P., Zammit, P. S. et al. (2013). Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet. 9, e1003415.
36. Lek, A., Rahimov, F., Jones, P. L. and Kunkel, L. M. (2015). Emerging preclinical animal models for FSHD. Trends Mol. Med. 21, 295-306.
37. Lemmers, R. J. L. F., van der Vliet, P. J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J. G., Snider, L., Straasheijm, K. R., van Ommen, G. J., Padberg, G. W. et al. (2010). A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653.
38. Lemmers, R. J. L. F., Tawil, R., Petek, L. M., Balog, J., Block, G. J., Santen, G. W. E., Amell, A. M., van der Vliet, P. J., Almomani, R., Straasheijm, K. R. et al. (2012). Digenic inheritance of an SMCHD1 mutation and an FSHDpermissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat. Genet. 44, 1370-1374.
39. Lu, M. J., Dadd, C. A., Mizzen, C. A., Perry, C. A., McLachlan, D. R., Annunziato, A. T. and Allis, C. D. (1994). Generation and characterization of novel antibodies highly selective for phosphorylated linker histone H1 in Tetrahymena and HeLa cells. Chromosoma 103, 111-121.
40. Mitsuhashi, H., Mitsuhashi, S., Lynn-Jones, T., Kawahara, G. and Kunkel, L. M. (2013). Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 22, 568-577.
41. Morgan, J. E. and Zammit, P. S. (2010). Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy. Exp. Cell Res. 316, 3100-3108.
42. Moyle, L. A. and Zammit, P. S. (2014). Isolation, culture and immunostaining of skeletal muscle fibres to study myogenic progression in satellite cells. Methods Mol. Biol. 1210, 63-78.
43. Padberg, G. W., Frants, R. R., Brouwer, O. F., Wijmenga, C., Bakker, E. and Sandkuijl, L. A. (1995). Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 18, Suppl. S13, S81-S84.
44. Relaix, F. and Zammit, P. S. (2012). Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139, 2845-2856.
45. Rickard, A. M., Petek, L. M. and Miller, D. G. (2015). Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways. Hum. Mol. Genet. 24, 5901-5914.
46. Sharma, V., Harafuji, N., Belayew, A. and Chen, Y.-W. (2013). DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS ONE 8, e64691.
47. Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3.
48. Snider, L., Asawachaicharn, A., Tyler, A. E., Geng, L. N., Petek, L. M., Maves, L., Miller, D. G., Lemmers, R. J. L. F., Winokur, S. T., Tawil, R. et al. (2009). RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet. 18, 2414-2430.
49. Snider, L., Geng, L. N., Lemmers, R. J. L. F., Kyba, M., Ware, C. B., Nelson, A. M., Tawil, R., Filippova, G. N., van der Maarel, S. M., Tapscott, S. J. et al. (2010). Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181.
50. Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppee, F. and Belayew, A. (2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J. Cell. Mol. Med. 17, 76-89.
51. Tawil, R. and Van Der Maarel, S. M. (2006). Facioscapulohumeral muscular dystrophy. Muscle Nerve 34, 1-15.
52. Tawil, R., van der Maarel, S. M. and Tapscott, S. J. (2014). Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet. Muscle 4, 12.
53. van den Boogaard, M. L., Lemmers, R. J. L. F., Balog, J., Wohlgemuth, M., Auranen, M., Mitsuhashi, S., van der Vliet, P. J., Straasheijm, K. R., van den Akker, R. F. P., Kriek, M. et al. (2016). Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am. J. Hum. Genet. 98, 1020-1029.
54. van Deutekom, J. C. T., Wijmenga, C., van Tienhoven, E. A. E., Gruter, A.-M., Hewitt, J. E., Padberg, G. W., van Ommen, G.-J. B., Hofker, M. H. and Fronts, R. R. (1993). FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037-2042.
55. van Overveld, P. G. M., Lemmers, R. J. F. L., Sandkuijl, L. A., Enthoven, L., Winokur, S. T., Bakels, F., Padberg, G.W., van Ommen, G.-J. B., Frants, R. R. and van der Maarel, S.M. (2003). Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35, 315-317.
56. Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton, S. D., Coppee, F. and Belayew, A. (2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS ONE 6, e26820.
57. Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppee, F., Ladner, K. J., Guttridge, D., Yang, J. and Harper, S. Q. (2010). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol. 69, 540-552.
58. Wijmenga, C., Hewitt, J. E., Sandkuijl, L. A., Clark, L. N., Wright, T. J., Dauwerse, H. G., Gruter, A.-M., Hofker, M. H., Moerer, P., Williamson, R. et al. (1992). Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 2, 26-30.
59. Winokur, S. T., Barrett, K., Martin, J. H., Forrester, J. R., Simon, M., Tawil, R., Chung, S.-A., Masny, P. S. and Figlewicz, D. A. (2003a). Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord. 13, 322-333.
60. Winokur, S. T., Chen, Y.W., Masny, P. S., Martin, J. H., Ehmsen, J. T., Tapscott, S. J., van der Maarel, S. M., Hayashi, Y. and Flanigan, K. M. (2003b). Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 12, 2895-2907.
61. Wu, S.-L., Li, G.-Z., Chou, C.-Y., Tsai, M.-S., Chen, Y.-P., Li, C.-J., Liou, G.-G., Chang, W.-W., Chen, S.-L. and Wang, S.-H. (2014). Double homeobox gene, Duxbl, promotes myoblast proliferation and abolishes myoblast differentiation by blocking MyoD transactivation. Cell Tissue Res. 358, 551-566.
62. Young, J. M., Whiddon, J. L., Yao, Z., Kasinathan, B., Snider, L., Geng, L. N., Balog, J., Tawil, R., van der Maarel, S. M. and Tapscott, S. J. (2013). DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet. 9, e1003947.
63. Zammit, P. S., Golding, J. P., Nagata, Y., Hudon, V., Partridge, T. A. and Beauchamp, J. R. (2004). Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J. Cell Biol. 166, 347-357.